Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Conditions: Hepatocellular Carcinoma; Portal Vein Tumor Thrombus; Liver Transplantation Interventions: Drug: lenvatinib; Drug: Placebo Sponsor: RenJi Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Hospitals | Liver | Liver Cancer | Liver Transplant | Research | Thrombosis | Transplants | Urology & Nephrology